company background image
4570 logo

Immuno-Biological Laboratories TSE:4570 Stock Report

Last Price

JP¥522.00

Market Cap

JP¥4.9b

7D

0.2%

1Y

-10.8%

Updated

12 Jul, 2024

Data

Company Financials

Immuno-Biological Laboratories Co., Ltd.

TSE:4570 Stock Report

Market Cap: JP¥4.9b

4570 Stock Overview

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

4570 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Immuno-Biological Laboratories Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Immuno-Biological Laboratories
Historical stock prices
Current Share PriceJP¥522.00
52 Week HighJP¥961.00
52 Week LowJP¥408.00
Beta0.37
11 Month Change0.77%
3 Month Change7.85%
1 Year Change-10.77%
33 Year Change1.75%
5 Year Change-25.75%
Change since IPO-41.35%

Recent News & Updates

Investors Shouldn't Be Too Comfortable With Immuno-Biological Laboratories' (TSE:4570) Earnings

May 22
Investors Shouldn't Be Too Comfortable With Immuno-Biological Laboratories' (TSE:4570) Earnings

We Think Immuno-Biological Laboratories (TSE:4570) Can Manage Its Debt With Ease

Feb 29
We Think Immuno-Biological Laboratories (TSE:4570) Can Manage Its Debt With Ease

Recent updates

Investors Shouldn't Be Too Comfortable With Immuno-Biological Laboratories' (TSE:4570) Earnings

May 22
Investors Shouldn't Be Too Comfortable With Immuno-Biological Laboratories' (TSE:4570) Earnings

We Think Immuno-Biological Laboratories (TSE:4570) Can Manage Its Debt With Ease

Feb 29
We Think Immuno-Biological Laboratories (TSE:4570) Can Manage Its Debt With Ease

Is Immuno-Biological Laboratories (TYO:4570) Using Debt In A Risky Way?

Feb 09
Is Immuno-Biological Laboratories (TYO:4570) Using Debt In A Risky Way?

Shareholder Returns

4570JP Life SciencesJP Market
7D0.2%-0.2%0.5%
1Y-10.8%-35.2%26.1%

Return vs Industry: 4570 exceeded the JP Life Sciences industry which returned -36.6% over the past year.

Return vs Market: 4570 underperformed the JP Market which returned 27.1% over the past year.

Price Volatility

Is 4570's price volatile compared to industry and market?
4570 volatility
4570 Average Weekly Movement4.8%
Life Sciences Industry Average Movement5.2%
Market Average Movement3.8%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 4570 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4570's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198257Tsutomu Seitowww.ibl-japan.co.jp

Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer’s disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies.

Immuno-Biological Laboratories Co., Ltd. Fundamentals Summary

How do Immuno-Biological Laboratories's earnings and revenue compare to its market cap?
4570 fundamental statistics
Market capJP¥4.86b
Earnings (TTM)JP¥186.00m
Revenue (TTM)JP¥816.00m

26.1x

P/E Ratio

6.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4570 income statement (TTM)
RevenueJP¥816.00m
Cost of RevenueJP¥300.00m
Gross ProfitJP¥516.00m
Other ExpensesJP¥330.00m
EarningsJP¥186.00m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 08, 2024

Earnings per share (EPS)19.97
Gross Margin63.24%
Net Profit Margin22.79%
Debt/Equity Ratio18.6%

How did 4570 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.